Ledger.Open graph →
SEC Form D · filed March 18, 2024

Perspective Therapeutics, Inc

Offering
$87.4M
Sold
$87.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Seattle, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Jonathan Hunt · Seattle, WAExecLori Woods · Seattle, WADirectorJohan (Thijs) Spoor · Seattle, WAExec · DirectorRobert Williamson Iii · Seattle, WADirectorMark Austin · Seattle, WAExecFrank Morich · Seattle, WADirectorMarkus Puhlmann · Seattle, WAExecHeidi Henson · Seattle, WADirectorLori Woods · Seattle, WADirectorJonathan Hunt · Seattle, WAExecHeidi Henson · Seattle, WADirectorMarkus Puhlmann · Seattle, WAExecMark Austin · Seattle, WAExecJohan (Thijs) Spoor · Seattle, WAExec · DirectorRobert Williamson Iii · Seattle, WADirectorFrank Morich · Seattle, WADirectorWill Shrank · New Orleans, LADirectorRebekah Gee · New Orleans, LADirectorDimitri Falk · New York, NYExec · DirectorMichael Fawkes · New York, NYDirectorJason Kimmel · New York, NYExecAdam Demuyakor · New York, NYDirectorLily Liu · New York, NYExecDickran D. Kurian · Encino, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗